Author's reply to comments to: Visual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month results

Eur J Ophthalmol. 2017 Jun 26;27(4):e135. doi: 10.5301/ejo.5000981.

Authors

Kaveh Abri Aghdam^{1

2}, Carsten Framme¹, Amelie Pielen¹, Bernd Junker¹

Affiliations

¹ University Eye Hospital, Hannover Medical School, Hannover - Germany.
² Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran - Iran.

PMID: 28497459
DOI: 10.5301/ejo.5000981

No abstract available

Publication types

Comment

MeSH terms

Humans
Receptors, Vascular Endothelial Growth Factor*
Recombinant Fusion Proteins
Wet Macular Degeneration*

Substances

Recombinant Fusion Proteins
aflibercept
Receptors, Vascular Endothelial Growth Factor